Yam ELY, Hsu LY, Peng-Huat Yap E, Yeo TW, Lee V, Schlundt J, et al. Antimicrobial resistance in the Asia Pacific region: a meeting report. Antimicrob Resist Infect Control. 2019;8:202–13.
PubMed PubMed Central Google Scholar
2.Tamma PD, Avdic E, Li DX, Dzintars K, Cosgrove SE. Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med. 2017;177(9):1308–15.
PubMed PubMed Central Google Scholar
3.FAO. Drivers, dynamics and epidemiology of antimicrobial resistance in animal production. Rome: Food and Agriculture Organization of the United Nations; 2016.
4.Millenium Development Goal 8. Access to affordable essential medicines. Delivering on the Global Partnership for Achieving the Millennium Development Goals. United Nations. New York: MDG Gap Task Force Report; 2008. p. 2008.
5.Torres NF, Solomon VP, Middleton LE. Patterns of self-medication with antibiotics in Maputo City: a qualitative study. Antimicrob Resist Infect Control. 2019;8:161–72.
PubMed PubMed Central Google Scholar
6.Franco BE, Martinez MA, Rodriguez MAS, Wertheimer AI. The determinants of the antibiotic resistance process. Infect Drug Resist. 2009;2:1–11.
CAS PubMed PubMed Central Google Scholar
7.• Davey P, Marwick CA, Scott CL, Charani E, McNeil K, Brown E. Interventions to improve antibiotic prescribing practices for hospital inpatients (Review). 2nd vol. [Online]. 2017. Available from: John Wiley & Sons, Ltd.: Cochrane Database of Systematic Review. [cited 2020 Apr 05]. This is an extensive review which evaluated the interventions for improving antimicrobial prescribing behavior.
8.•• Michie S, van Stralen MM, West R. The behaviour change wheel: A new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6:42–52 This is an excellent article which deals with the interventions and policies for behavioral change which in turn can be an effector in prescribing habits.
PubMed PubMed Central Google Scholar
9.Klein EY, Van Boeckel TP, Martinez EM, Pant S, Gandra S, Levin SA, et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci. 2018;115(15):E3463–70.
10.Martins V. Council Directive 92/28/EEC of 31 March 1992 on the advertising of medicinal products for human use. Official Journal of the European Communities (OJEC). 1992;L 113:13–18.
11.WHO, WHO Global Strategy for Containment of Antimicrobial Resistance. WHO/CDS/CSR/DRS/2001.2. Switzerland: World Health Organization; 2001.
12.Gupta YK, Ramachandran SS. Fixed dose drug combinations: issues and challenges in India. Indian J Pharmacol. 2016;48(4):347–9.
PubMed PubMed Central Google Scholar
13.WHO. Counterfeit drugs: report of a joint WHO/IFPMA workshop; 1992 April 1–3. Geneva: World Health Organization; 1992.
14.Afari-Asiedu S, Kinsman J, Boamah-Kaali E, Abdulai MA, Gyapong M, Sankoh O, et al. To sell or not to sell; the differences between regulatory and community demands regarding access to antibiotics in rural Ghana. J Pharm Policy Pract. 2018;11:30–9.
PubMed PubMed Central Google Scholar
15.Means AR, Weaver MR, Burnett SM, Mbonye MK, Naikoba S, McClelland RS. Correlates of inappropriate prescribing of antibiotics to patients with malaria in Uganda. PLoS One. 2014;9(2):e90179.
PubMed PubMed Central Google Scholar
16.Mukonzo JK, Namuwenge PM, Okure G, Mwesige B, Namusisi OK, Mukanga D. Over-the-counter suboptimal dispensing of antibiotics in Uganda. J Multidiscip Healthc. 2013;6:303–10.
PubMed PubMed Central Google Scholar
17.Ahmed SM, Alam BB, Anwar I, Begum T, Huque R, Khan JAM, et al. Bangladesh health system review. In: Naheed A, Hort K, editors. Health systems in transition. Asia Pacific Observatory on Health Systems and Policies. Geneva: WHO; 2015. 5(3).
18.Kanjlal B, Mondal S, Samanta T, Mondal A, Singh S. A parallel health care market: rural medical practitioners in West Bengal, India. Future Health Systems Research. Institute of Health Management Research: Jaipur; 2007.
19.Sudhinaraset M, Ingram M, Lofthouse HK, Montagu D. What is the role of informal healthcare providers in developing countries? A systematic review. PLoS One. 2013;8(2):e54978.
CAS PubMed PubMed Central Google Scholar
20.Das J, Chowdhury A, Hussam R, Banerjee AV. The impact of training informal health care providers in India: a randomized controlled trial. Science. 2016;354(6308):80–91.
21.Pathak D, Pathak A, Marrone G, Diwan V, Lundborg CS. Adherence to treatment guidelines for acute diarrhoea in children up to 12 years in Ujjain, India - a cross-sectional prescription analysis. BMC Infect Dis. 2011;11:32–40.
PubMed PubMed Central Google Scholar
22.McGettigan P, Roderick P, Kadam A, Pollock A. Threats to global antimicrobial resistance control: centrally approved and unapproved antibiotic formulations sold in India. Br J Clin Pharmacol. 2019;85:59–70.
23.Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob Resist Infect Control. 2017;6:47–54.
PubMed PubMed Central Google Scholar
24.WHO. WHO Global Surveillance and Monitoring System for substandard and falsified medical products. Switzerland: World Health Organization; 2017.
25.Frost I. Craig J, Joshi J, Faure K, Laxminarayan R. Access barriers to antibiotics. Center for Disease Dynamics, Economics and Policy. Washington, DC: CDDEP; 2019.
26.Laximinarayan R, Boeckel TV, Teillant A. Global antimicrobial use in the livestock sector. Paris: Organisation for Economic Co-operation and Development. OECD; 2015.
27.Van Boeckel TP, Brower C, Gilbert M, Grenfell BT, Levin SA, Robinson TP, et al. Global trends in antimicrobial use in food animals. Proc Natl Acad Sci. 2015;112(18):5649–54.
PubMed PubMed Central Google Scholar
28.Dhanarani TS, Shankar C, Park J, Dexilin M, Kumar RR, Thamaraiselvi K, et al. Study on acquisition of bacterial antibiotic resistance determinants in poultry litter. Poult Sci. 2009;88:1381–7.
29.Suresh T, Hatha AAM, Sreenivasan D, Sangeetha N, Lashmanaperumalsamy P. Prevalence and antimicrobial resistance of Salmonella enteritidis and other salmonellas in the eggs and egg-storing trays from retail markets of Coimbatore. South India. Food Microbiol. 2006;23(3):294–9.
30.Brower CH, Mandal S, Hayer S, Sran M, Zehra A, Patel SJ, et al. The prevalence of extended-spectrum beta-lactamase-producing multidrug-resistant Escherichia coli in poultry chickens and variation according to farming practices in Punjab, India. Environ Health Perspect. 2017;125(7):077015.
PubMed PubMed Central Google Scholar
31.Food safety and Standards Authority of India. Comments with regard to placing of meat and poultry products on the Indian market. New Delhi: Ministry of Health and Family Welfare, Government of India; 2015.
32.WHO. Global action plan on antimicrobial resistance. Geneva: World health organization; 2015.
33.Industry Roadmap for Progress on Combating Antimicrobial Resistance. AMR Industry Alliance. Geneva; 2016.
34.Limited Population Pathway for Antibacterial and Antifungal Drugs. Guidance for Industry. U.S. Department of Health and Human Services; 2018.
35.WHO. The 2019 WHO AWaRe classification of antibiotics for evaluation and monitoring of use. Geneva: World Health Organization; 2019.
36.National Policy for Containment of Antimicrobial Resistance in India. Directorate General of Health Services. Ministry of Health & Family Welfare. In: New Delhi; 2011.
37.Ghafur A, Mathai D, Muruganathan A, Jayalal JA, Kant R, Chaudhary D, et al. “The Chennai Declaration” recommendations of “A roadmap to tackle the challenge of antimicrobial resistance”—a joint meeting of medical societies of India. Indian J Cancer. 2012;49(4):71–81.
38.The Gazette of India. G.S.R [online]. 2013 Aug 30 [cited 2020 Mar 23]; 558E. Available from: URL:https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MTM0NA==
39.National Action Plan on Antimicrobial Resistance (NAP AMR) 2017–2021. Antibiotics: use with care. New Delhi: Ministry of Health and Family Welfare; 2017.
40.National Guidelines for Infection Prevention and Control in Healthcare Facilities. National Centre for Disease Control. Directorate General of Health Services. Ministry of Health and Family Welfare. In: New Delhi; 2020.
41.Antimicrobial Resistance National Strategy Framework 2014-2024. National department of Health. Pretoria: Department: Health, Republic of South Africa; 2014.
42.Goff DA, Kullar R, Goldstein EJC, Gilchrist M, Nathwani D, Cheng AC, et al. A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail. Lancet Infect Dis. 2017;17:e56–63.
43.Xiao Y. A National Action Plan to contain antimicrobial resistance in China: contents, actions and expectations [online]. 2016 Aug 26 [cited 2020 Jul 10]. Available from: URL:http://resistancecontrol.info/2017/a-national-action-plan-to-contain-antimicrobial-resistance-in-china-contents-actions-and-expectations/
44.National Action Plan on combatting drug resistance in the period from 2013-2020. Hanoi: Ministry of Health; 2013.
45.Armstrong D, Ogden J. The role of etiquette and experimentation in explaining how doctors change behaviour: a qualitative study. Sociol Health Illn. 2006;28(7):951–68.
46.Lewis PJ, Tully MP. Uncomfortable prescribing decisions in hospitals: the impact of teamwork. J R Soc Med. 2009;102:481–8.
PubMed PubMed Central Google Scholar
47.Schouten JA, Hulscher MEJL, Natsch S, Kullberg BJ, van der Meer JWM, Grol RPTM. Barriers to optimal antibiotic use for community-acquired pneumonia at hospitals: a qualitative study. Qual Saf Health Care. 2007;16(2):143–9.
PubMed PubMed Central Google Scholar
48.Rodrigues AT, Roque F, Falcão A, Figueiras A, Herdeiro MT. Understanding physician antibiotic prescribing behaviour: a systematic review of qualitative studies. Int J Antimicrob Agents. 2013 Mar;41(3):203–12.
49.Butler CC, Rollnick S, Pill R, Maggs-Rapport F, Stott N. Understanding the culture of prescribing: qualitative study of general practitioners’ and patients’ perceptions of antibiotics for sore throats. Br Med J. 1998;317(7159):637–42.
50.Kumar S, Little P, Britten N. Why do general practitioners prescribe antibiotics for sore throat? Grounded theory interview study. Br Med J. 2003;326(7381):138–43.
51.Kotwani A, Wattal C, Katewa S, Joshi PC, Hollowayd K. Factors influencing primary care physicians to prescribe antibiotics in Delhi India. Fam Pract. 2010;27(6):684–90.
52.Liabsuetrakul T, Chongsuvivatwong V, Lumbiganon P, Lindmark G. Obstetricians’ attitudes, subjective norms, perceived controls, and intentions on antibiotic prophylaxis in caesarean section. Soc Sci Med. 2003;57(9):1665–74.
53.Norrby SR. Antibiotic resistance: a self-inflicted problem. J Intern Med. 1996;239:373–5.
54.Kiguba R, Karamagi C, Bird SM. Extensive antibiotic prescription rate among hospitalized patients in Uganda: but with frequent missed-dose days. J Antimicrob Chemother. 2016;71(6):1697–706.
CAS PubMed PubMed Central Google Scholar
55.Chandy SJ, Thomas K, Mathai E, Antonisamy B, Holloway KA, Lundborg CS. Patterns of antibiotic use in the community and challenges of antibiotic surveillance in a lower-middle-income country setting: a repeated cross-sectional study in Vellore, South India. J Antimicrob Chemother. 2013;68(1):229–36.
56.Currie J, Lin W, Zhang W. Patient knowledge and antibiotic abuse: evidence from an audit study in China. J Health Econ. 2011;30(5):933–49.
57.Macfarlane J, Holmes W, Macfarlane R, Britten N. Influence of patients’ expectations on antibiotic management of acute lower respiratory tract illness in general practice: questionnaire study. Br Med J. 1997;315(7117):1211–4.
Comments (0)